Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression.
Co-Principal Investigator
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer. J Clin Oncol. 2018 03 20; 36(9):884-890.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Benzamides
Female
Humans
Immunohistochemistry
Kaplan-Meier Estimate
Middle Aged
Neoplasm Metastasis
Nitriles
Phenylthiohydantoin
Receptors, Androgen
Triple Negative Breast Neoplasms
authors with profiles
Rita Nanda